Takeda Pharmaceutical Company Limited (TKDA) — Free Cash Flow Generation Index
Takeda Pharmaceutical Company Limited (TKDA) has a Free Cash Flow Generation Index of 0.40x as of December 2025. Free cash flow of €150.88 Billion represents 0% of operating cash flow (€373.25 Billion). Read how much debt does Takeda Pharmaceutical Company Limited carry for a breakdown of total debt and financial obligations.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
Takeda Pharmaceutical Company Limited Free Cash Flow Generation Index (2017–2025)
Historical FCF Generation Index trend for Takeda Pharmaceutical Company Limited across 9 annual periods. Explore reinvestment intensity of Takeda Pharmaceutical Company Limited to see what proportion of operating cash flow is directed to capital expenditures.
Annual Free Cash Flow Generation for Takeda Pharmaceutical Company Limited (2017–2025)
Year-by-year Free Cash Flow Generation Index for Takeda Pharmaceutical Company Limited. For the full company profile including market capitalisation, see TKDA company net worth.
| Year | FCG Index | Free Cash Flow (EUR) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.64x | €677.56 Billion | €1.06 Trillion | €379.62 Billion | ▲ +94.9% |
| 2024 | 0.33x | €235.61 Billion | €716.34 Billion | €480.73 Billion | ▼ -6.4% |
| 2023 | 0.35x | €343.47 Billion | €977.16 Billion | €633.69 Billion | ▼ -57.9% |
| 2022 | 0.83x | €937.07 Billion | €1.12 Trillion | €123.25 Billion | ▲ +8.9% |
| 2021 | 0.77x | €774.46 Billion | €1.01 Trillion | €111.21 Billion | ▲ +13.5% |
| 2020 | 0.67x | €452.04 Billion | €669.75 Billion | €127.08 Billion | ▲ +14.1% |
| 2019 | 0.59x | €194.37 Billion | €328.48 Billion | €77.68 Billion | ▼ -10.4% |
| 2018 | 0.66x | €249.59 Billion | €377.85 Billion | €67.00 Billion | ▼ -46.6% |
| 2017 | 1.24x | €323.02 Billion | €261.36 Billion | €61.66 Billion | — |